🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the number of infusion reactions to treat...
Status
Completed
Location
St.Joseph Heritage Care
Start Date
2020-03-25
Trial ID
NCT04189588
Treatments Being Tested
SUMMARY: This is a multi-center open label study to evaluate the safety and...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2005-10
Trial ID
NCT00139841
Treatments Being Tested
The hypothesis of this study is that lymphocyte depletion by Campath-1H and...
Status
Terminated
Location
University of Wisconsin
Start Date
2006-04
Trial ID
NCT00579592
Treatments Being Tested
This study will determine the overall response rate and toxicity of rituxim...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2004-12
Trial ID
NCT00201877
This study is researching an experimental drug called odronextamab, referre...
Status
Recruiting
Location
Mayo Clinic - Arizona
Start Date
2023-12-13
Trial ID
NCT06091865
Treatments Being Tested
To learn if cyclophosphamide, vincristine, and dexamethasone (called mini h...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-07-14
Trial ID
NCT05645718
The combination of mitoxantrone and clofarabine as reinduction therapy will...
Status
Completed
Location
New York Medical College
Start Date
2013-03
Trial ID
NCT01842672
Treatments Being Tested
The purpose of this trial is to measure the safety and effectiveness of epc...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-11-03
Trial ID
NCT04663347
Treatments Being Tested
This open-label, multicenter, Phase 1/1b study will evaluate the safety, to...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2015-08-04
Trial ID
NCT02453087
Treatments Being Tested
This Phase 2, two-arm, open-label study is designed to evaluate the safety,...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2017-02-28
Trial ID
NCT03003520
Treatments Being Tested